Author

Tim Kohrn

Medizinische Hochschule Hannover

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Assay:scRNA-seq· 1 Approach:statistical model· 1 Research Focus:variant calling· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

Ulrich MartiniD· 2 shared Aileen Schmidt· 1 shared Anna Evgenevna Kuleshova· 1 shared Anna Melchert· 1 shared Arjang RuhparwariD· 1 shared Astrid WeißiD· 1 shared Carola VossiD· 1 shared Clara PlötneriD· 1 shared

Activity by Year

2021-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

Ulrich MartinORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

iPSC modeling of pulmonary arterial hypertension to uncover pathomechanisms and unrecognized modes of action of sotatercept

Aileen Schmidt, Laurien Czichon, Leonie Malhofer, Gioia Bartsch, Clara Plötner, Yuepeng Wang, Carola Voss, Anna Evgenevna Kuleshova, Tim Kohrn, Julia Baldauf, Astrid Weiß, RALPH THEO SCHERMULY, Arjang Ruhparwar, Jan C. Kamp, Marius M. Hoeper, , Ruth Olmer

This study uses patient-derived iSMCs to uncover new mechanisms of PAH and sotatercept's effects beyond its known anti-proliferative actions.

bioRxiv · Oct 30, 2026 · PreprintCell Biology

iPSC culture expansion selects against putatively actionable mutations in the mitochondrial genome

Maike Kosanke, Colin Davenport, Mónika Szepes, Lutz Wiehlmann, Tim Kohrn, Marie Dorda, Jonas Gruber, Kaja S. Menge, Maike Sievert, Anna Melchert, Ina Gruh, Gudrun Göhring, Ulrich Martin

The paper analyzes mtDNA variants in iPSCs and finds that culture expansion selects against harmful mitochondrial mutations, while reprogramming and differentiation do not significantly alter mtDNA heteroplasmy.

Stem Cell Reports · Sep 23, 2021Peer-reviewedGenomics